What are CHF notes in CTVS patient
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Searching the Web
CHF notes CTVS patient preoperative assessment cardiothoracic surgery
I now have comprehensive material to give a thorough answer. Let me compile the complete CHF notes for CTVS patients.
CHF Notes in CTVS Patient
"CHF notes" in the context of a Cardiothoracic and Vascular Surgery (CTVS) patient refers to the clinical documentation and management points related to Congestive Heart Failure - covering preoperative assessment, pathophysiology, perioperative fluid/drug management, and postoperative care. Here is a structured breakdown:
1. Definition & Pathophysiology
CHF occurs when cardiac output fails to meet the hemodynamic and metabolic demands of the body. The underlying mechanisms involve:
- Systolic dysfunction - reduced contractility (low EF)
- Diastolic dysfunction - poor ventricular compliance and filling
- Neurohumoral activation - persistent RAAS and sympathetic nervous system (SNS) stimulation causing salt/water retention, tachycardia, and vasoconstriction
The four primary determinants that can be deranged in CHF:
- Excessive preload (e.g., large L→R shunts, severe anemia)
- Decreased contractility (e.g., myocarditis, cardiomyopathy)
- Excessive afterload (e.g., aortic stenosis, hypertension)
- Rhythm abnormalities (e.g., AF, SVT, heart block)
(Rosen's Emergency Medicine)
2. NYHA Functional Classification (Used in CTVS Notes)
| Class | Description |
|---|---|
| I | No symptoms with ordinary activity |
| II | Symptoms with moderate exertion |
| III | Symptoms with minimal exertion |
| IV | Symptoms at rest |
- AF prevalence in heart failure ranges from 10% in NYHA Class I to 50% in Class IV
- Pre-op documentation should include NYHA class
(Braunwald's Heart Disease)
3. Clinical Features (Examination Notes)
- Tachycardia, S3 gallop
- Tachypnea with bibasal rales
- Hepatomegaly
- Peripheral/dependent edema
- Decreased peripheral perfusion
- Chronic cough or wheezing ("cardiac asthma")
- Raised JVP
(Rosen's Emergency Medicine)
4. Diagnostic Workup (Pre-CTVS Notes)
| Investigation | Finding in CHF |
|---|---|
| Chest X-ray | Cardiomegaly, pulmonary congestion, pleural effusion |
| ECG | LVH, AF, bundle branch block |
| Echocardiogram | EF assessment, wall motion abnormalities, valvular disease |
| BNP / NT-proBNP | >400 pg/mL (BNP) or >2000 pg/mL (NT-proBNP) suggests CHF |
| Labs | Renal function, electrolytes (K⁺, Mg²⁺), CBC, LFTs |
| Coronary angiogram | If ischemic etiology suspected |
BNP is particularly useful to differentiate cardiac from pulmonary causes of dyspnea and to monitor treatment response.
(Tietz Textbook of Laboratory Medicine; Goldman-Cecil Medicine)
5. Preoperative Optimization in CTVS Patients
Goals Before Surgery:
- Patient must be clinically euvolemic before any cardiac surgery
- Optimize ongoing heart failure medications
- Correct electrolyte disturbances
- Assess and document fluid status carefully
Key Concerns:
- Poorly compliant ventricles require adequate preload AND adequate diastolic filling time
- The flattened Starling curve means excessive fluid causes "forward failure" (poor perfusion) AND "backward failure" (pulmonary/peripheral edema)
- Tachycardia must be avoided - increases O₂ demand and worsens myocardial function
(Miller's Anesthesia, 10e)
6. Drug Management Notes - Perioperative
| Drug Class | Use | Perioperative Concern |
|---|---|---|
| Beta-blockers | Rate control, reduce SNS activation | Continue; blunt sympathetic response |
| Diuretics (Furosemide) | Volume control | May cause hypovolemia, hypokalemia, hypomagnesemia |
| ACE inhibitors / ARBs | Afterload reduction | Blunt sympathetic/angiotensin response; hypotension at induction - treat with vasopressors/vasopressin analogues |
| Aldosterone antagonists (Spironolactone) | RAAS blockade | Risk of hyperkalemia, especially with ACEi + CKD |
| Digoxin | Rate control in AF | Hypokalemia potentiates toxicity - electrolytes must be normalized |
| Amiodarone | Rhythm control | Safe in HF (unlike most other antiarrhythmics) |
| Inotropes (Dobutamine, Milrinone) | Acute decompensation | Used perioperatively for low cardiac output state |
(Miller's Anesthesia, 10e)
7. Perioperative Fluid Management
Two goals:
- Preserve cardiac output - balance preload, contractility, afterload. Avoid both hypovolemia and hypervolemia.
- Minimize cardiac work - avoid tachycardia; prevent the cycle of increased O₂ demand → inadequate supply → worsening myocardial function.
Monitoring required for moderate or major CTVS surgery:
- Transesophageal echocardiography (TEE) - gold standard in cardiac surgery
- Pulmonary artery catheter (PAC) - in complex cases
- Less invasive cardiac output monitors
Large volumes of any fluid, including blood products, should only be given with objective evidence of intravascular volume loss.
(Miller's Anesthesia, 10e)
8. Specific CTVS Surgical Considerations
In patients with low EF / systolic dysfunction:
- High-risk for postoperative low cardiac output syndrome (LCOS)
- Consider preoperative IABP (intra-aortic balloon pump) in severe cases
- Post-bypass inotropic support frequently required
AF in Heart Failure (common in CTVS patients):
- Rate control: Beta-blockers + Digoxin (first line for systolic HF)
- Rhythm control: Amiodarone or Dofetilide (only agents safe in HF)
- AF catheter ablation improves LVEF, exercise capacity, and reduces mortality in HF
- After AV node ablation: institute biventricular pacing; if EF likely to remain <30-35%, biventricular ICD is appropriate
(Braunwald's Heart Disease)
Left Ventricular Aneurysm / SVR (Surgical Ventricular Restoration):
- ~67% of patients preoperatively in NYHA Class III/IV
- ~85% improve to NYHA Class I/II postoperatively
(Schwartz's Principles of Surgery)
9. Active Cardiac Conditions Requiring Optimization Before CTVS
Per ACC/AHA guidelines (documented in preoperative notes):
- Decompensated heart failure (uncontrolled CHF, NYHA Class IV)
- Unstable coronary syndromes
- Significant arrhythmias
- Severe valvular disease
These conditions warrant cardiac consultation and optimization before elective CTVS surgery.
(Current Surgical Therapy 14e; Goldman-Cecil Medicine)
10. Summary CHF Note Template for CTVS Patient
DIAGNOSIS: Congestive Heart Failure - [Systolic / Diastolic / Mixed]
ETIOLOGY: [Ischemic / Non-ischemic / Valvular / Hypertensive]
EF: ___% (Echo dated: ___)
NYHA CLASS: ___ (I/II/III/IV)
SYMPTOMS: Dyspnea on exertion / rest, orthopnea, PND, peripheral edema
SIGNS: S3 gallop, rales, JVP raised, pedal edema
INVESTIGATIONS: CXR (cardiomegaly, pulmonary congestion), ECG, Echo, BNP: ___ pg/mL
CURRENT MEDICATIONS: ACEi/ARB, Beta-blocker, Diuretic, Digoxin, Aldosterone antagonist
ELECTROLYTES: K⁺: ___, Mg²⁺: ___, Na⁺: ___
VOLUME STATUS: [Euvolemic / Hypervolemic - needs optimization]
RENAL FUNCTION: Cr: ___, eGFR: ___
OPTIMIZATION PLAN: [Diuresis, electrolyte correction, echo-guided assessment]
ANESTHETIC CONCERNS: Careful fluid balance, TEE monitoring, vasopressor/inotrope plan
RISK ASSESSMENT: [Low/Intermediate/High risk CTVS procedure]
Sources: Miller's Anesthesia (10e), Braunwald's Heart Disease, Rosen's Emergency Medicine, Schwartz's Principles of Surgery, Goldman-Cecil Medicine, Current Surgical Therapy 14e
This is a shared conversation. Sign in to Orris to start your own chat.